Chimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumors.
Cervical cancer is caused by persistent high-risk human papillomavirus (HR-HPV) infection and represents the second most frequent gynecological malignancy in the world. The HPV-16 type accounts for up to 55% of all cervical cancers. The HPV-16 oncoproteins E6 and E7 are necessary for induction and m...
Main Authors: | Juan Martin Caballero, Ana Garzón, Leticia González-Cintado, Wioleta Kowalczyk, Ignacio Jimenez Torres, Gloria Calderita, Margarita Rodriguez, Virgínia Gondar, Juan Jose Bernal, Carlos Ardavín, David Andreu, Thomas Zürcher, Cayetano von Kobbe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3534127?pdf=render |
Similar Items
-
Design of a Novel and Potent Multi-Epitope Chimeric Vaccine against Human Papillomavirus (HPV): An Immunoinformatics Approach
by: Muhammad Shahab, et al.
Published: (2023-05-01) -
EVALUASI VAKSIN INFECTIOUS BURSAL DISEASE (IBD) BERDASARKAN PADA NILAI INDEKS BURSAL
by: Soedijar, Ida
Published: (2010) -
EVALUASI VAKSIN INFECTIOUS BURSAL DISEASE (IBD) BERDASARKAN PADA NILAI INDEKS BURSAL
by: Perpustakaan UGM, i-lib
Published: (2010) -
Bursal Restoration After Intermediate And Intermediate Plus Infectious Bursal Disease Virus Vaccination
by: María Castro, et al.
Published: (2009-07-01) -
Recombinant chicken interleukin-7 as a potent adjuvant increases the immunogenicity and protection of inactivated infectious bursal disease vaccine
by: Dan Cui, et al.
Published: (2018-02-01)